Lane Simonian
Contributor since: 2015
Articles
Biogen's Important Year: Challenges To Tecfidera And Aducanumab
How The FDA's Decision On Aducanumab May Affect The Value Of Biogen's Stock
Anavex 2-73 And Neurological Disorders: A Possible Path Forward
Biogen And Neurotrope: Why Numbers Cannot Overcome Alzheimer's Disease
Biogen And Eisai's Aducanumab And Green Valley's GV-971: A Contrasting Tale Of 2 Charts
Biogen And Eisai's Aducanumab: All That Glitters Is Not Gold
Biogen, Amyloid, And Alzheimer's Disease: Once More Down The Rabbit Hole
Anavex, Glovia, And India Globalization Capital: The Future Of Alzheimer's Treatments
Biohaven, Anavex, And Neurotrope: Addressing The Role Of Protein Kinase C In Alzheimer's Disease
Pfizer And INmune Bio: Seeking The Blockade Of Tumor Necrosis Factor Alpha For Alzheimer's Disease
Biogen: The End Of The Amyloid Era For Alzheimer's Disease?
Anavex 2-73 And Alzheimer's Disease: A Partial Picture
Biohaven's Trigriluzole: A Contender In The Race To Treat Alzheimer's Disease?
Roche, Biogen, And The Achilles' Heel Of Alzheimer's Drug Development
Neurotrope And Alzheimer's Disease: A Placebo Problem Or A Placebo Solution?
Alzheimer's Pathways: An Investor's Guide To Biogen, Anavex, And Neurotrope
Biogen: One More Time Around The Alzheimer's Block
Biogen Results: Time To Change The Paradigm In Alzheimer's Disease
Biogen And Alzheimer's Disease: Reasons For Caution
Alzheimer's Disease: A History Of Drug Failures
Anavex 2-73: Addressing The Causes Of Alzheimer's Disease
Neurotrope And The Missing Step In Alzheimer's Disease
Anavex 2-73 And The Stabilization Of Alzheimer's Disease
Biogen, Neurotrope, Anavex And The Future Of Alzheimer's Treatments
Anavex And Alzheimer's Disease At The Crossroads
The Curious Case Of Neurotrope
Alzheimer's Disease: Anavex 2-73 And The Long Road Home
Why The Anti-Amyloid Approach To Alzheimer's Disease Has Failed
Alzheimer's Disease: A Case For Combination Therapy
Alzheimer's Disease: 40 Years In The Wilderness
Neurotrope: Lessons Learned
Alzheimer's Disease: What's Next?